Journal of Biological Chemistry · 2003 · 56 citations · 20 references
Life SciencesCell BiologyPharmacologyCell SignalingMembrane TraffickingSignal TransductionG Protein-coupled Receptor SignalingMembrane ReceptorsPolarized TraffickingReceptor PhysiologyReceptor RegulationReceptor-mediated SignalingCamp SignalingCell Surface GlycoproteinsEndoglycosidase ActivityG-protein-coupled ReceptorsGlycoprotein TraffickingMembrane Receptor LocalizationMembrane Trafficking Of ReceptorsReceptor Trafficking Dynamics
To understand the mechanisms of G protein-coupled receptor delivery and steady state localization, we examined the trafficking itineraries of wild type (WT) and mutant V2 vasopressin receptors (V2Rs) in polarized Madin-Darby canine kidney II (MDCK II) cells and in COS M6 cells; the mutant V2Rs represent selected alleles responsible for X-linked nephrogenic diabetes insipidus. The WT V2R is localized on the plasma membrane and mediates arginine vasopressin (AVP)-stimulated cAMP accumulation, whereas the clinically relevant V2R mutants, L292P V2R, ΔV278 V2R, and R337X V2R, are retained intracellularly, are insensitive to extracellularly added AVP, and are not processed beyond initial immature glycosylation, manifest by their endoglycosidase H sensitivity. Reduced temperature and pharmacological, but not chemical, strategies rescue mutant V2Rs to the cell surface of COS M6 cells; surface rescue of L292P V2R and R337X V2R, but not of ΔV278 V2R, parallels acquisition of AVP-stimulated cAMP production. Pharmacological rescue of the L292P or R337X V2R by incubation with the membrane-permeant V2R antagonist, SR121463B, leads to a mature glycosylated form of the receptor that achieves localization on the basolateral surface of polarized MDCK II cells indistinguishable from that of the WT V2R. Surprisingly, however, the immature form of the mutant L292P V2R escapes to the apical, but not basolateral, surface of polarized MDCK II cells, even in the absence of SR121463B. These findings are consistent with the interpretation that the receptor conformation that allows appropriate processing through the N-linked glycosylation pathway is also essential for V2R targeting to the appropriate surface of polarized epithelial cells. To understand the mechanisms of G protein-coupled receptor delivery and steady state localization, we examined the trafficking itineraries of wild type (WT) and mutant V2 vasopressin receptors (V2Rs) in polarized Madin-Darby canine kidney II (MDCK II) cells and in COS M6 cells; the mutant V2Rs represent selected alleles responsible for X-linked nephrogenic diabetes insipidus. The WT V2R is localized on the plasma membrane and mediates arginine vasopressin (AVP)-stimulated cAMP accumulation, whereas the clinically relevant V2R mutants, L292P V2R, ΔV278 V2R, and R337X V2R, are retained intracellularly, are insensitive to extracellularly added AVP, and are not processed beyond initial immature glycosylation, manifest by their endoglycosidase H sensitivity. Reduced temperature and pharmacological, but not chemical, strategies rescue mutant V2Rs to the cell surface of COS M6 cells; surface rescue of L292P V2R and R337X V2R, but not of ΔV278 V2R, parallels acquisition of AVP-stimulated cAMP production. Pharmacological rescue of the L292P or R337X V2R by incubation with the membrane-permeant V2R antagonist, SR121463B, leads to a mature glycosylated form of the receptor that achieves localization on the basolateral surface of polarized MDCK II cells indistinguishable from that of the WT V2R. Surprisingly, however, the immature form of the mutant L292P V2R escapes to the apical, but not basolateral, surface of polarized MDCK II cells, even in the absence of SR121463B. These findings are consistent with the interpretation that the receptor conformation that allows appropriate processing through the N-linked glycosylation pathway is also essential for V2R targeting to the appropriate surface of polarized epithelial cells. Extensive investigation has revealed several mechanisms that modulate G protein-coupled receptor (GPCR) 1The abbreviations used are: GPCR, G protein-coupled receptor; α2-AR, α2-adrenergic receptor; AVP, arginine vasopressin; Δ, deletion (as in ΔV278, deletion of Val278); Endo H, endoglycosidase H; HA, hemagglutinin; HERG, human ether-a-go-go-related gene; MDCK, Madin-Darby canine kidney; NDI, nephrogenic diabetes insipidus; NHS, sulfo-N-hydroxysuccinimide; PBS, phosphate-buffered saline; PNGase F, peptide:N-glycosidase F; X, Stop (as in R337X, Arg337 → Stop); V2R, V2 vasopressin receptor; WT, wild type; DMEM, Dulbecco's modified Eagle's medium; TEMED, N,N,N′,N′-tetramethylethylenediamine. responsiveness following agonist occupancy, including receptor relocalization (reviewed in Refs. 1Ferguson S.S. Pharmacol. Rev. 2001; 53: 1-24PubMed Google Scholar and 2Tsao P. Zastrow M. Curr. Opin. Neurobiol. 2000; 10: 365-369Crossref PubMed Scopus (135) Google Scholar). However, less attention has focused on the molecular mechanisms accounting for how receptors achieve localization in the agonist-naive state. A key determinant governing the specificity of GPCR signaling entails appropriate receptor localization on the cell surface, permitting access to requisite ligands and signal transduction machinery. Cell surface localization is governed by two predominant mechanisms: 1) receptor delivery to a particular site and 2) retention at that site. The functional importance of GPCR localization is emphasized by diseases that result from receptor mislocalization, such as retinitis pigmentosa, X-linked nephrogenic diabetes insipidus (NDI), and hypogonadotropic hypogonadism (3Leanos-Miranda A. Janovick J.A. Conn P.M. J. Clin. Endocrinol. Metab. 2002; 87: 4825-4828Crossref PubMed Scopus (109) Google Scholar), which result from intracellular accumulation of mutant rhodopsin, the V2 vasopressin receptor (V2R), or the gonadotropin-releasing hormone receptor, respectively. Our previous studies have exploited α2-AR subtypes as a model for characterization of GPCR trafficking and localization because of their different trafficking itineraries in polarized cells and in response to agonist (reviewed in Ref. 4Saunders C. Limbird L.E. Pharmacol. Ther. 1999; 84: 193-205Crossref PubMed Scopus (111) Google Scholar). All three α2-AR subtypes (α2A-, α2B-, and α2C-AR) are located, at steady state, at the basolateral surface in polarized Madin-Darby canine kidney (MDCK) II cells, analogous to their localization in vivo (5Keefer J.R. Limbird L.E. J. Biol. Chem. 1993; 268: 11340-11347Abstract Full Text PDF PubMed Google Scholar, 6Wozniak M. Limbird L.E. J. Biol. Chem. 1996; 271: 5017-5024Abstract Full Text Full Text PDF PubMed Scopus (87) Google Scholar). However, they achieve this basolateral localization via different trafficking itineraries. Whereas the α2A-AR and α2C-AR are directly targeted to the basolateral surface, the α2B-AR is randomly distributed to both the apical and basolateral surface and then selectively retained at the lateral subdomain (6Wozniak M. Limbird L.E. J. Biol. Chem. 1996; 271: 5017-5024Abstract Full Text Full Text PDF PubMed Scopus (87) Google Scholar). Truncations of the α2A-AR and chimeras with the apically targeted A1 adenosine receptor reveal that α2A-AR targeting to the basolateral surface relies upon multiple, non-contiguous, membrane-embedded sequences within or near the lipid bilayer (7Keefer J.R. Kennedy M.E. Limbird L.E. J. Biol. Chem. 1994; 269: 16425-16432Abstract Full Text PDF PubMed Google Scholar, 8Saunders C. Keefer J.R. Bonner C.A. Limbird L.E. J. Biol. Chem. 1998; 273: 24196-24206Abstract Full Text Full Text PDF PubMed Scopus (29) Google Scholar), suggesting that a three-dimensional surface provides the basis for interaction with trafficking molecules. Consequently, it can be reasoned that no single linear sequence can be exploited to identify receptor targeting machinery. Thus, to elucidate the mechanisms involved in basolateral delivery of GPCRs, we explored the human V2R and naturally occurring point mutations in the V2R responsible for the pathogenesis of X-linked NDI. Many of the >160 human mutations described to date cause the receptor to be retained intracellularly (9Oksche A. Rosenthal W. J. Mol. Med. 1998; 76: 326-337Crossref PubMed Scopus (117) Google Scholar), to arginine vasopressin examined the trafficking and localization of the wild type V2R and three intracellularly retained V2R to be and and cell surface rescue also by localization on the appropriate surface of polarized MDCK II cells. wild type (WT) and mutant V2R by or by and from from from from TEMED, and from and from The and the the of the V2R from and the from the from and the from from and from The and membrane from from Dulbecco's modified Eagle's and by the cell by the and at All Cell MDCK II cell WT and mutant V2Rs the as described (7Keefer J.R. Kennedy M.E. Limbird L.E. J. Biol. Chem. 1994; 269: 16425-16432Abstract Full Text PDF PubMed Google Scholar). of or human wild type (WT) or mutant R337X, and with of MDCK II cells. selected on to a and as described (7Keefer J.R. Kennedy M.E. Limbird L.E. J. Biol. Chem. 1994; 269: 16425-16432Abstract Full Text PDF PubMed Google Scholar). for WT V2R by of the V2R cell via the the or the and WT V2R MDCK II cells in with and at kidney cells in The studies in the WT V2R cell which the WT V2R at a of of of in not be for the mutant V2R cell because a V2R to the L292P V2R and R337X V2R that is for we have no that the ΔV278 V2R AVP, AVP-stimulated cAMP is not following temperature or rescue of this mutant receptor to the surface of COS M6 cells. However, V2R be by for the in from cells the WT V2R cell is as then L292P is of the of MDCK II cells in the absence of rescue and of this The R337X V2R is of V2R but to of V2R with the WT V2R cell from (as to following M6 cells the to at a of or the of cells in to incubation with a or of with for at The and with with and and at for this the and the cells to in DMEM, at with to of localization of the WT V2R, R337X V2R, and L292P V2R in MDCK II cell via of the apical or basolateral surface of polarized MDCK II cells with as described of the cell via (7Keefer J.R. Kennedy M.E. Limbird L.E. J. Biol. Chem. 1994; 269: 16425-16432Abstract Full Text PDF PubMed Google Scholar). to Cell of MDCK II of V2R to the cell surface examined by and surface as described (6Wozniak M. Limbird L.E. J. Biol. Chem. 1996; 271: 5017-5024Abstract Full Text Full Text PDF PubMed Scopus (87) Google Scholar, J.R. Kennedy M.E. Limbird L.E. J. Biol. Chem. 1994; 269: 16425-16432Abstract Full Text PDF PubMed Google Scholar). MDCK II cells WT V2R in for to a in with the of the at the apical or basolateral surface with two of and and at for and the with and to A and Limbird L.E. 2000; PubMed Scopus Google Scholar). The with and the at The to on The for in to and to are from of strategies also can of the of surface receptors (MDCK COS or apical basolateral receptors (MDCK even of COS M6 cells or the appropriate of of polarized of WT or mutant V2R in MDCK II cells with on the apical or basolateral surface as described (6Wozniak M. Limbird L.E. J. Biol. Chem. 1996; 271: 5017-5024Abstract Full Text Full Text PDF PubMed Scopus (87) Google Scholar, J.R. Kennedy M.E. Limbird L.E. J. Biol. Chem. 1994; 269: 16425-16432Abstract Full Text PDF PubMed Google Scholar). MDCK II cells in with to achieve rescue or not to surface The cells with and the at The at with The and as Limbird L.E. 2000; PubMed Scopus Google Scholar), and the by on The to as described and the V2R by the of V2R with from or from not a of and to the by with H in or with peptide:N-glycosidase in for at of the and WT V2R MDCK II cells or COS M6 cells on M6 or in (MDCK II and for or to with for cells in PBS, with in for and with in for at and cells with and with to incubation with a of for at cells three in a of in with added as the to the cells and in the for at a of and a of then to on with The or used as the in the on a a at or on a in the Cell cAMP or cAMP accumulation in cells by the of COS M6 cells in the following and the cell and at with in DMEM, or SR121463B. To the of in temperature to surface of mutant V2R, cells for at wild type cells and as studies of AVP-stimulated cAMP and rescue to COS M6 cells. we achieve surface rescue with in MDCK II cells, we not to AVP-stimulated cAMP accumulation in polarized or MDCK II following with to of this by temperature is not in MDCK II cells, in to COS M6 cells. the response for AVP-stimulated cAMP accumulation in WT cells as a of SR121463B, we that that in COS M6 cell to of AVP-stimulated cAMP accumulation not in the V2R from MDCK II cells. AVP-stimulated cAMP accumulation, even in WT cells, which are to with or also not from MDCK II cells not have for this the that the of V2Rs in MDCK II cells for WT the of the receptor in cells, this is a cell whereas the for WT in COS M6 cells a of for cells the receptor and cells no the receptor cell in COS M6 cells receptor to even in the of SR121463B. cAMP in WT and mutant MDCK II cells and that the is in the cells and that is to cAMP in MDCK II cells they also cAMP in WT MDCK II cells not with as a the of the of cAMP accumulation, COS M6 cells with cell by a single with then with and with a for cells with selected of for in a of by of and to of of in then on for which the to with of and with with of by at The to and to are as The of from the from the as PubMed Scopus Google Scholar). To trafficking of the WT V2R to as WT V2R with clinically relevant V2R we examined the localization of following in COS M6 cells. of cells in the incubation with revealed that the WT V2R on the cell surface it also be at intracellular cells with intracellular as as surface of the WT V2R in COS M6 cells is a result of the of the V2R in cells, receptor processing as described M. A. P. M. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). of cells the selected V2R L292P V2R, ΔV278 V2R, and R337X V2R no cell surface no cells not V2R with cells in the absence of These three mutant receptors are however, they are the is in the of that of V2R is but is retained intracellularly with receptor also by the intracellularly V2R be to the cell surface, their be cells mutant V2R with or or at cells to a that can rescue intracellularly by J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google no on the of mutant V2Rs on the WT V2R with The of surface in cells not to in of the V2R but intracellularly examined in cells not with the membrane-permeant V2R V2R at the surface for mutant examined that of cell surface of selected V2R mutants, to or of receptors their in intracellular J. M. Pharmacol. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar, A. A. M. M. J. Clin. 2000; PubMed Scopus Google Scholar). COS M6 cells to temperature cell surface localization of the V2R to with rescue suggesting that is for appropriate and trafficking for in COS M6 cells. cell surface strategies in COS M6 cells to the delivery of mutant V2R to the surface following rescue with temperature or SR121463B, WT V2R as a as in we the of WT V2R on the surface as in we that of the WT V2R in COS M6 cells on the surface in the absence of SR121463B. leads to rescue of the L292P V2R from to of WT V2R surface the R337X V2R from to of WT V2R surface and the ΔV278 V2R from to of WT V2R surface of the receptor at the surface following to SR121463B, of the WT V2R, R337X V2R, and ΔV278 V2R in the mature glycosylated whereas of the L292P V2R in the mature glycosylated form not V2R in COS M6 cells and to less mutant V2R at the cell surface in to findings for rescue by SR121463B, of the R337X and ΔV278 V2R that the cell surface achieves the mature glycosylated of the L292P V2R achieves the mature glycosylated These that of the R337X and ΔV278 V2R by a single or of V2R that achieve mature glycosylation, whereas incubation of cells at is L292P to the mature glycosylated which be in for V2R in polarized MDCK II cells. V2R to the surface of AVP, to G and we examined cAMP accumulation following rescue COS M6 cells WT V2R or V2R mutant at or and for or AVP-stimulated cAMP WT or mutant V2Rs no in cAMP accumulation at or A and Whereas of cells WT V2R in cAMP accumulation, cells of the V2R at to cAMP However, to that plasma membrane receptor localization, the V2R L292P V2R and R337X V2R of and AVP-stimulated cAMP accumulation the ΔV278 V2R to following incubation at surface localization of this mutant receptor Thus, the ΔV278 V2R can be to with the L292P or R337X V2R this X-linked also signaling J. 1998; PubMed Scopus Google Scholar). have rescue to the cell surface also cAMP for receptors that manifest functional rescue following incubation at in for V2R of cells the L292P V2R to a of cAMP consistent with findings following at the of this mutant to at the cell temperature and rescue of the L292P and R337X mutant V2R mutant V2Rs of cAMP with wild type V2R and response for mutant receptors by incubation at revealed that L292P V2R and R337X V2R a in their to cAMP as as a These findings to to the L292P V2R and R337X V2R, even following surface rescue by COS M6 cells at temperature not The of this receptor for agonist to in the or in to G of via to the of the receptor signal in the cAMP accumulation we are to a functional receptor (as by to to to the cell surface and that temperature and V2R signaling in cells the R337X V2R, previous studies that the R337X V2R functional following A. A. M. M. J. Clin. 2000; PubMed Scopus Google Scholar). whereas this a the receptor of the A. M. Rosenthal W. Mol. Pharmacol. 1998; PubMed Scopus Google Scholar, A. M. Rosenthal W. 1998; PubMed Scopus Google Scholar), findings that R337X V2R can to the surface that V2R to the are not for V2R to consistent with previous findings chimeras that V2R to is by the intracellular of the V2R J. J. J. Biol. Chem. 1996; 271: Full Text Full Text PDF PubMed Scopus Google Scholar). To the of the human WT V2R and steady state localization, we the WT V2R in epithelial (MDCK II) cells, a model that the of the trafficking of surface to polarized C. Limbird L.E. Pharmacol. Ther. 1999; 84: 193-205Crossref PubMed Scopus (111) Google Scholar, J.R. Limbird L.E. J. Biol. Chem. 1993; 268: 11340-11347Abstract Full Text PDF PubMed Google Scholar, 6Wozniak M. Limbird L.E. J. Biol. Chem. 1996; 271: 5017-5024Abstract Full Text Full Text PDF PubMed Scopus (87) Google Scholar, J.R. Kennedy M.E. Limbird L.E. J. Biol. Chem. 1994; 269: 16425-16432Abstract Full Text PDF PubMed Google Scholar, 8Saunders C. Keefer J.R. Bonner C.A. Limbird L.E. J. Biol. Chem. 1998; 273: 24196-24206Abstract Full Text Full Text PDF PubMed Scopus (29) Google Scholar). in the the of the V2R that this receptor is at the cell surface a of cells that this is at the lateral subdomain The of in MDCK II cells provides that the is to the WT V2R in this MDCK II cell The of V2R in polarized MDCK II cells is consistent with the basolateral localization of V2R in To we and surface strategies to the delivery of the WT V2R to the basolateral allows for the of the of receptor that is to a particular surface or in polarized MDCK II cells and has for receptor delivery of of the α2-AR subtypes as as C. Limbird L.E. Pharmacol. Ther. 1999; 84: 193-205Crossref PubMed Scopus (111) Google Scholar, J.R. Limbird L.E. J. Biol. Chem. 1993; 268: 11340-11347Abstract Full Text PDF PubMed Google Scholar, 6Wozniak M. Limbird L.E. J. Biol. Chem. 1996; 271: 5017-5024Abstract Full Text Full Text PDF PubMed Scopus (87) Google Scholar, J.R. Kennedy M.E. Limbird L.E. J. Biol. Chem. 1994; 269: 16425-16432Abstract Full Text PDF PubMed Google Scholar, 8Saunders C. Keefer J.R. Bonner C.A. Limbird L.E. J. Biol. Chem. 1998; 273: 24196-24206Abstract Full Text Full Text PDF PubMed Scopus (29) Google Scholar). in the WT V2R to be directly to the basolateral surface, the of WT V2R is in from MDCK II cells, whereas WT V2R is from the apical membrane is These findings have following not that the receptor is to the basolateral surface and at steady state. These findings and of previous A. J. Rosenthal W. 1998; PubMed Scopus Google that WT V2R is on the basolateral surface of polarized MDCK II cells. The V2R that achieve signaling surface rescue in COS M6 cells also in of MDCK II cells. in with the WT V2R, the mutant V2Rs are retained intracellularly following in MDCK II cells in and are not the is to MDCK II cells in the absence of polarized MDCK II cells, COS M6 cells, temperature is not as as in COS M6 cells for surface rescue of mutant and rescue at this temperature for MDCK II cells is in to at not However, with at a of the mutant V2Rs to the surface and with H and To the localization of mutant V2Rs following the basolateral the apical of MDCK II cells and the of basolateral apical signal for V2R with or with in studies the WT V2R is selectively targeted to the basolateral surface of of the WT V2R is at this surface with or SR121463B. the WT V2R, of the mutant R337X and of the L292P V2Rs on the basolateral surface rescue with and of the R337X V2R achieves at the basolateral surface R337X V2R have mature N-linked glycosylation indistinguishable from the WT receptor the L292P V2R, rescue also in basolateral of a mature glycosylated form of the receptor but this of the L292P V2R Surprisingly, in the absence of SR121463B, the L292P V2R at the apical surface this apical by of the L292P V2R in the absence of to of the L292P V2R following apically L292P V2R the immature glycosylated form of the receptor, on and and and to Endo H not of the V2R can be by to Endo H and PNGase WT V2Rs at and V2R also can be and at J. 1998; PubMed Scopus Google Scholar). The molecular form is to endoglycosidase H, that the immature glycosylated of cell surface PubMed Scopus Google Scholar), suggesting that this is a of the WT V2R. the WT V2R is to by PNGase F, which PubMed Scopus Google Scholar), but is insensitive to endoglycosidase H, suggesting that the form the form of the The PNGase form of the mature WT V2R is not to a consistent with V2R on the of the of is because the V2R is also and are to the endoglycosidase H or M. 1999; PubMed Scopus Google Scholar). The mutant L292P V2R and R337X V2R at and temperature or These to the immature glycosylation of two receptor as by their to both endoglycosidase H and PNGase and receptor localization essential in permitting cells to to also at in receptors and in surface of receptors to mutations a in the of as by Limbird L.E. Pharmacol. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). the of human alleles of the V2R model in this of the mutations that to X-linked are to intracellular receptor accumulation Rev. 2001; PubMed Scopus Google Scholar). V2Rs cells are to the AVP, which not the membrane mutant V2R in to and cAMP and to the apical surface of Rev. 2001; PubMed Scopus Google Scholar). The studies three clinically relevant mutant ΔV278, and R337X, that alleles mutant receptors that are Our findings are the to that alleles are and can be to the surface by incubation of mutant COS M6 cells at temperature To findings represent the V2R that manifest have described and of the GPCR J. PubMed Scopus Google Scholar), the J. PubMed Scopus Google Scholar), and the J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). These to that are result in retention within in temperature is to manifest as cell surface as is the for the V2R examined The studies also that X-linked V2R can be to the surface by of a membrane-permeant V2R by with alleles of the V2R A. A. M. M. J. Clin. 2000; PubMed Scopus Google Scholar). however, that rescue to the surface is not to achieve V2R as by the ΔV278 V2R. mutant not to cAMP following surface suggesting that this has to or both J. J. J. Biol. Chem. 1996; 271: Full Text Full Text PDF PubMed Scopus Google Scholar). L292P V2R and R337X V2R, rescue to the surface, not manifest cAMP as the WT V2R. Thus, the of cAMP that alleles can achieve is with WT V2R, and the for cAMP in response to is consistent with the interpretation that or to is in the L292P and R337X V2R rescue at the intracellularly V2R immature glycosylated of the receptor and are to by endoglycosidase basolateral delivery of L292P V2R and R337X V2R for the mature glycosylated form of the it that rescue to the appropriate surface of polarized epithelial cells a conformation of the receptor that is of through the to achieve mature N-linked glycosylation as as delivery to targeted However, this interpretation is not to that receptor glycosylation is for basolateral mutations of the WT V2R that of the receptor not basolateral targeting M. Mol. Pharmacol. 1996; Google Scholar). These findings are to for GPCRs, such as the receptor; mutations that N-linked glycosylation of the receptor not basolateral delivery of the receptor (7Keefer J.R. Kennedy M.E. Limbird L.E. J. Biol. Chem. 1994; 269: 16425-16432Abstract Full Text PDF PubMed Google Scholar). the of a for N-linked glycosylation of the V2R for basolateral delivery by that incubation with in the of N-linked glycosylation of V2R, but V2Rs targeted to the basolateral surface of polarized MDCK II cells not of that appropriate delivery to the basolateral surface a conformation of the V2R that is also of mature glycosylation and through the to targeted in the we to that a of the immature glycosylated form of the L292P V2R is to the cell surface in the absence of or rescue but that this delivery is to the surface of polarized MDCK II cells we this apical L292P V2R on the apical surface in and not by pathway the immature glycosylated form of the L292P V2R the apical however, this apically L292P V2R to by Endo H, that it immature glycosylated form of the the glycosylated form of the L292P V2R is on the basolateral surface These are consistent with of to intracellularly L292P V2R, in of a of the V2R in a conformation of both mature glycosylation and localization to the appropriate that it is for the L292P V2R that we to the apical be because this is to within the bilayer of the V2R and to of the receptor, of which a is in the of SR121463B. R337X V2R a with a in the and not be as as for the L292P V2R. we rescue of the mature form of R337X L292P V2R to the basolateral surface cell in the absence the of SR121463B, following the V2R mutants, such as in J. PubMed Scopus Google and the in J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar), have to be in trafficking but are of wild to the cell the rescue of cell surface and receptor of the L292P and R337X V2R alleles to that the of with membrane-permeant V2R for of X-linked has the to be in with particular because the mature form of the receptor is selectively to the basolateral not be by the findings of apical delivery of immature of mutant V2R because is to the basolateral surface of epithelial cells. of and mutant V2R alleles provides for and of molecular involved in appropriate V2R GPCR in and delivery to the cell surface of polarized cells. are to Bonner for and to of the Limbird for and also of for and for the V2R, V2R, and V2R from The membrane-permeant V2R a from
20
Ulla E. Petäjä‐Repo, Mireille Hogue, André Laperrière et al. · Journal of Biological Chemistry · 2000 · 288 citations · Full text